# A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)

> **NCT04775303** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 90 (estimated)

## Conditions studied

- Moderate to Severe Dry Eye

## Interventions

- **DRUG:** Cyclosporine 0.1% (Ikervis®) eye drop

## Key facts

- **NCT ID:** NCT04775303
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-25
- **Primary completion:** 2022-01
- **Final completion:** 2022-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04775303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04775303, "A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04775303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*